Thrombectomy Devices Market Size, Share, Trends - Analysis Report 2022
According to research report the Thrombectomy Devices Market is expected to reach USD 1.45 Billion by 2022 growing at a CAGR of 6.7%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801
This
large thrombectomy devices market share is mainly attributed to factors
such as increasing prevalence of cardiovascular diseases across major
markets, higher prevalence of thrombotic diseases among geriatric
individuals, procedural benefits offered by mechanical thrombectomy in
cardiac surgeries and growing preference of surgeons for image-guided
and minimally invasive cardiac surgeries.
Asia-Pacific
thrombectomy devices market is expected to grow at the highest CAGR
during 2017-2022. This is primarily due to the presence of large target
patient population, increasing healthcare expenditure, increase in
localized manufacturing & strengthening of distribution networks,
and rising awareness among surgeons related to the benefits offered by
thrombectomy devices.
On the basis of application, the global
thrombectomy procedure market is segmented into neurovascular,
cardiovascular, and peripheral vascular applications. The cardiovascular
applications segment accounted for the largest share of the market in
2016. The large share of this segment is attributed to the increasing
prevalence of cardiovascular diseases, procedural benefits offered by
mechanical thrombectomy in cardiac surgeries, higher prevalence of
thrombotic diseases among geriatric individuals, and growing preference
of surgeons for image-guided and minimally invasive cardiac surgeries.
On
the basis of type, the global thrombectomy devices market is segmented
into aspiration, mechanical/fragmentation, rheolytic/hydrodynamic, and
ultrasonic thrombectomy devices. The mechanical/fragmentation
thrombectomy devices segment accounted for the largest share of the
market in 2016. This large share is attributed to the ongoing
commercialization of mechanical thrombectomy products, favorable
reimbursement scenario, established therapeutic efficacy, growing market
demand for stent retrievers among medical professionals, and rising
end-user preference for minimally invasive thrombectomy procedures.
On
the basis of end users, the global thrombectomy procedure market is
segmented into hospitals & surgical centers, ambulatory surgical
centers, research laboratories & academic institutes, and other end
users. The highest CAGR of the ambulatory surgical centers segment is
mainly attributed to increasing availability of reimbursement for
thrombectomy procedures in outpatient settings, ongoing advancements in
minimally invasive surgical techniques, increasing number of
image-guided surgeries performed at ASCs, and rising market demand for
miniaturized therapeutic devices.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222966801
some
of the major players in the global thrombectomy devices market are
Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific
Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.),
Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards
Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and
Teleflex Incorporated (U.S.).
Comments
Post a Comment